Skip to main content
Microbix Biosystems Inc. (MBXBF)
OTCMKTS · Delayed Price · Currency is USD
0.2500
-0.0100 (-3.85%)
May 15, 2025, 1:11 PM EDT

Revenue by Product

Fiscal year is October - September.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2017 - 2019
Antigens,Quality Assessment Products and DxTM
21.31M
Log In
Log In
Log In
Log In
Upgrade
Antigens,Quality Assessment Products and DxTM Growth
40.51%
Log In
Log In
Log In
Log In
Upgrade
Other (includes Kinlytic)
4.09M
Log In
Log In
Log In
Log In
Upgrade
Other (includes Kinlytic) Growth
202.60%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is October - September.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2017 - 2019
North America
19.05M
Log In
Log In
Log In
Log In
Upgrade
North America Growth
75.84%
Log In
Log In
Log In
Log In
Upgrade
Europe
6.01M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
5.91%
Log In
Log In
Log In
Log In
Upgrade
Other Foreign Countries
332.61K
Log In
Log In
Log In
Log In
Upgrade
Other Foreign Countries Growth
8288.63%
Log In
Log In
Log In
Log In
Upgrade